Related Experiment Videos
Drug-induced liver disease
1Department of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
Abstract:
The incidence of drug-induced liver disease appears to be increasing, reflecting the increasing number of new agents that have been introduced into clinical use over the past several decades. Among the topics covered, the author discusses incidence, diagnosis, risk factors, clinical presentations, hepatitis, and vascular injury. The author also reviews the hepatic injury seen with commonly prescribed drugs, emphasizing newer developments in the field and recent publications and reports.
Insights
Drug-induced liver disease is rising with new medications. This review covers its incidence, diagnosis, risk factors, presentations, and injury patterns from common drugs.
Area of Science:
- Hepatology
- Clinical Pharmacology
Background:
- The increasing introduction of novel pharmaceutical agents has coincided with a rise in drug-induced liver disease (DILD).
- Understanding DILD is crucial due to its growing prevalence and potential for severe hepatic injury.
Purpose of the Study:
- To provide a comprehensive overview of the current understanding of drug-induced liver disease.
- To highlight recent developments, publications, and reports concerning DILD.
Main Methods:
- Literature review of incidence, diagnosis, risk factors, and clinical presentations of DILD.
- Analysis of hepatic injury patterns associated with commonly prescribed medications.
- Focus on newer developments and recent publications in the field.
Main Results:
- The incidence of DILD is increasing, linked to the expanding array of available drugs.
- Key aspects discussed include hepatitis and vascular injury as manifestations of DILD.
- The review emphasizes hepatic injury from frequently used drugs, incorporating recent findings.
Conclusions:
- The rising incidence of DILD necessitates continued vigilance and research.
- Accurate diagnosis, risk factor identification, and understanding of clinical presentations are vital.
- Ongoing review of drug safety and hepatic injury patterns is essential for clinical practice.